Slide 1: Interim Report Quarter 3, 2025
Interim Report Quarter 3, 2025 October 23, 2025
Slide 2: Highlights Q3 2025
Highlights Q3 2025 Organic sales growth EBITA excl. IAC • Positive organic sales growth with higher prices, positive volumes and product mix +4.6% SEK • Higher margins +0.9% Organic: 5,056m +3.8% • Strong cash flow • Impactful innovations EBITA margin excl. IAC EPS • Measures launched to accelerate
Slide 3: Health & Medical
Health & Medical Business highlights • Growing Medical Solutions for 18 consecutive quarters • Good growth across therapy areas – Wound Care, Compression and Orthopedics • Incontinence Products Health Care back to volume growth • Launch of Actimove Manus Air – a breakthrough in treatment of wrist fr
Slide 4: Consumer Goods
Consumer Goods Business highlights • Continued strong growth in Incontinence Products Retail • Feminine Care growth remained high • Baby Care sales improved with market share gains for Libero in Nordics • Consumer Tissue volumes down in Europe, but record high sales for Regio in Mexico • Superiority
Slide 5: Professional Hygiene
Professional Hygiene Business highlights • Continued challenging market conditions, especially in HoReCa • Positive volume growth vs Q2 • Strong growth in Latin America, stable in Europe and negative in North America • Strong growth in premium products • Selective price management and launch of valu
Slide 6: Sales development
Sales development Higher prices, positive volumes and mix Positive organic sales growth SEK 36.3bn +0.2% +0.7% -5.4% in all business areas: SEK 34.6bn Health & Medical +1.7% + Health & Medical - Health & Medical + Consumer Goods + Consumer Goods • Incontinence Health Care +0.7% - Professional Hygien
Slide 7: Margin development
Margin development Higher gross and EBITA margins excl IAC +80bps -10bps -10bps -10bps 14.6% 14.1% + Higher sales prices + Higher volumes + Lower COGS EBITA margin excl. IAC Health & Medical 18.3% Consumer Goods 12.7% Professional Hygiene 18.3% Q3 2024 Impact Gross A&P SG&A Other Q3 2025 Profit Marg
Slide 8: Operating cash flow
Operating cash flow Strong cash flow generation 6.5 6.1 SEKbn 5.9 5.3 4.3 3.8 3.2 3.3 1.5 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Interim Report, Quarter 3, 2025 8
Slide 9: Balance sheet
Balance sheet Continued reduction of net debt SEKbn 70 5 62.9 4,5 60 53.7 4 50 3,5 3 40 3.1 30.8 30.3 2,5 30 2 20 2.0 1,5 1 10 1.2 1.2 0,5 0 0 2022 2023 2024 9M 2025 Net Debt, SEKbn Net Debt / EBITDA excl. IAC Interim Report, Quarter 3, 2025 9
Slide 10: Financial targets
Financial targets Annual organic EBITA margin sales growth >3% excl. IAC >15%
Slide 11: Accelerating profitable growth
Accelerating profitable growth Grow in Deliver Capture Focus on Differentiated, Strong attractive superior efficiencies high yielding insight-based performance geographic customer across the segments innovations culture areas experience value chain
Slide 12: Significant potential to fuel growth and improve performance
Significant potential to fuel growth and improve performance • Realizing Essity’s full potential requires sharper focus on the most attractive categories and segments • Stronger end-to-end accountability, decentralized decision-making and less operational complexity will unlock the full power of the
Slide 13: Actions to fuel growth and improve performance
Actions to fuel growth and improve performance Reshaping Cost savings the organization program Unlocking the power of the organization, freeing up resources to accelerate profitable growth and maximizing the potential of Essity’s product portfolio
Slide 14: Summary
Summary • Positive organic sales growth, higher margins and strong cash flow in Q3 • Measures launched to fuel growth and improve performance • Priorities – Continue efforts to accelerate profitable volume growth in a challenging market – Achieve SG&A and COGS savings – Reshape the organization to b
Slide 15: Every day our brands care for the hygiene and health of a billion people
This presentation may contain forward-looking statements. Such statements are based on our current expectations and are subject to certain risks and uncertainties that could negatively affect our business. Please read our most recent annual report for a better understanding of these risks and uncert
Slide 16: Q&A
Q&A
Slide 17: essity
essity